[TLX] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
28-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -40.20%
YoY- 181.56%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 188,963 220,834 24,047 2,910 1,607 1,818 49 295.50%
PBT 9,143 -12,300 -70,703 -37,046 -25,096 -17,125 -5,190 -
Tax -2,537 2,020 188 -4,532 -6,795 -6,756 -471 32.36%
NP 11,680 -14,320 -70,891 -32,514 -18,301 -10,370 -5,190 -
Tax Rate 27.75% - - - - - - -
Total Cost 177,283 235,154 94,938 35,424 19,908 12,187 5,239 79.75%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 6.18 -6.48 -294.80 -1,117.32 -1,138.83 -570.54 -10,638.53 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.03 -0.05 -0.23 -0.12 -0.07 -0.05 -0.03 -
EPS Diluted 0.03 -0.05 -0.23 -0.12 -0.07 -0.05 -0.03 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.